微创引流尿激酶血肿腔注射治疗慢性硬膜下血肿66例临床分析
Effect of Drainage by Needle Puncturing into Hematoma and Urokinase Injection on Chronic Subdural Hematoma in 66 Cases
-
摘要: 目的观察微创引流加尿激酶血肿腔注射对慢性硬膜下血肿治疗效果.方法 2003年1月至12月共有118例患者接受了微创血肿穿刺手术,其中,52例手术后仅保持引流,2007年开始66例手术后接受了1~3次不等的血肿腔尿激酶注射.结果 66例接受了血肿腔尿激酶注射者,血肿引流干净的平均时间为4.1 d,均无复发;而没有接受尿激酶注射的患者有5例复发,血肿引流干净的平均时间为5.4 d,两者经统计学检验差异有统计学意义(P<0.05).结论慢性硬膜下血肿应首选微创穿刺引流手术,随后在CT监测下向血肿腔注射尿激酶,可以尽可能地清除残留的血块,缩短手术后引流时间,最大程度减少血肿复发.Abstract: Objective To explore the effect of minimally invasive drainage and urokinase injection on chronic subdural hematoma.Methods 118 patients have been treated with needle puncturing into hematoma since 2003.Among them,52 patients were only drained after puncture,since 2007,other 66 patients were injected urokinase into hematoma for one to third times after puncture.Results The average time of hematoma complete drainage for 66 patients who accepted urokinase injection into hematoma was 4.1 days,and no recurrence...
-
Key words:
- Chronic subdural hematoma /
- Recurrence /
- Puncture /
- Hematoma injection /
- Urokinase
点击查看大图
计量
- 文章访问数: 1953
- HTML全文浏览量: 725
- PDF下载量: 26
- 被引次数: 0